Heartflow, Inc. Common Stock
NASDAQ:HTFLMedical - Healthcare Information Services
+$0.39 today
- Market cap
- $4.03B
- Beta
- 1.91
- P/E (TTM)
- -109.5
- EPS (TTM)
- -$0.30
Volume 1.33M
Average 1.33M
HTFL Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Heartflow, Inc. Common StockNASDAQ: HTFL
Deferred Revenue · Q3 FY2026 · quarter ended Sep 2026
Deferred revenue rises 126.2% from a year ago
Deferred revenue stood at $1.18M at the end of Q3 FY2026, up 126.2% from a year earlier.
Context
- Deferred revenue amounted to 0.3% of total assets at the end of Q3 FY2026, up 0.2 pp from a year earlier.
- Deferred revenue increased in 0 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether deferred revenue keeps rising in the next quarterly balance sheet after a +126.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 627K USD
- Year-over-year change
- -39.8%
- 2-year CAGR
- -45.5%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 627K | -39.8% |
| FY2024 | 2024-12-31 | 1.04M | -50.6% |
| FY2023 | 2023-12-31 | 2.11M | — |
Deferred Revenue vs competitors
How HTFL compares with its peers on the latest reported figures
No competitor Deferred Revenue figures are available to compare.
Balance Sheet
Heartflow, Inc. Common Stock
NASDAQ:HTFL
Intrinsic Alpha fair value
Locked
Current Price
$45.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.